Medicover AB (publ)
MCVEF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.13B
Close$
$14.20
47.9% downside
Current Fair Value
47.9% downsideOvervalued by 47.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.13 Billion |
|---|---|
| Enterprise Value | $5.53 Billion |
| Annual dividend | $0.23 |
| Dividend yield | 0.80% |
| Earnings per Share | $0.51 |
| Beta | 1.5 |
| Outstanding Shares | 151,656,945 |
Return
| Return on Equity | 15.86% |
|---|---|
| Return on Assets | 3.49% |
| Return on Invested Capital | 11.89% |
Valuation & Multiples
| P/E Ratio | 44.31 |
|---|---|
| PEG | 156.74 |
| Price to Sales | 1.7 |
| Price to Book Ratio | 9.08 |
| Enterprise Value to Revenue | 2.23 |
| Enterprise Value to EBIT | 31.58 |
| Enterprise Value to Net Income | 64 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 2.77 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 22, 2026
EPS Estimate
$0.19
Consensus analyst estimateRevenue Estimate
$728.21 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.19
Consensus analyst estimateRevenue Estimate
$684.71 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Medicover AB (publ)
49,000 employees
CEO: John Paul Stubbington
Medicover AB (publ) delivers healthcare and diagnostic solutions across multiple countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. The company operates through...